Literature DB >> 20100758

Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis.

Daniel C Payne1, Kathryn M Edwards, Michael D Bowen, Erin Keckley, Jody Peters, Mathew D Esona, Elizabeth N Teel, Diane Kent, Umesh D Parashar, Jon R Gentsch.   

Abstract

Although rotavirus vaccines are known to be shed in stools, transmission of vaccine-derived virus to unvaccinated contacts resulting in symptomatic rotavirus gastroenteritis has not been reported to our knowledge. We document here the occurrence of vaccine-derived rotavirus (RotaTeq [Merck and Co, Whitehouse Station, NJ]) transmission from a vaccinated infant to an older, unvaccinated sibling, resulting in symptomatic rotavirus gastroenteritis that required emergency department care. Results of our investigation suggest that reassortment between vaccine component strains of genotypes P7[5]G1 and P1A[8]G6 occurred during replication either in the vaccinated infant or in the older sibling, raising the possibility that this reassortment may have increased the virulence of the vaccine-derived virus. Both children remain healthy 11 months after this event and are without underlying medical conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100758     DOI: 10.1542/peds.2009-1901

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  37 in total

1.  Rotavirus VP7 epitope chimeric proteins elicit cross-immunoreactivity in guinea pigs.

Authors:  Bingxin Zhao; Xiaoxia Pan; Yumei Teng; Wenyue Xia; Jing Wang; Yuling Wen; Yuanding Chen
Journal:  Virol Sin       Date:  2015-10-10       Impact factor: 4.327

2.  An infant with acute gastroenteritis caused by a secondary infection with a Rotarix-derived strain.

Authors:  Naomi Sakon; Ryohei Miyamoto; Jun Komano
Journal:  Eur J Pediatr       Date:  2017-07-21       Impact factor: 3.183

3.  Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).

Authors:  David O Matson; Timo Vesikari; Penelope Dennehy; Michael D Dallas; Michelle G Goveia; Robbin F Itzler; Max Ciarlet
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Multiple Introductions and Antigenic Mismatch with Vaccines May Contribute to Increased Predominance of G12P[8] Rotaviruses in the United States.

Authors:  Kristen M Ogden; Yi Tan; Asmik Akopov; Laura S Stewart; Rendie McHenry; Christopher J Fonnesbeck; Bhinnata Piya; Maximilian H Carter; Nadia B Fedorova; Rebecca A Halpin; Meghan H Shilts; Kathryn M Edwards; Daniel C Payne; Mathew D Esona; Slavica Mijatovic-Rustempasic; James D Chappell; John T Patton; Natasha B Halasa; Suman R Das
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

5.  Horizontal transmission of live vaccines.

Authors:  Prasad S Kulkarni; Suresh S Jadhav; Rajeev M Dhere
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

Review 6.  Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.

Authors:  Keith Grimwood; Stephen B Lambert; Richard J Milne
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

7.  Monitoring Shedding of Five Genotypes of RotaTeq Vaccine Viruses by Genotype-Specific Real-Time Reverse Transcription-PCR Assays.

Authors:  Yuki Higashimoto; Masaru Ihira; Yu Miyazaki; Ayumi Kuboshiki; Sayaka Yoshinaga; Hiroyuki Hiramatsu; Ryota Suzuki; Masafumi Miyata; Hiroki Miura; Satoshi Komoto; Jun Yukitake; Koki Taniguchi; Yoshiki Kawamura; Tetsushi Yoshikawa
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

8.  Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series.

Authors:  Julie A Boom; Leila C Sahni; Daniel C Payne; Rashi Gautam; Freda Lyde; Slavica Mijatovic-Rustempasic; Michael D Bowen; Jacqueline E Tate; Marcia A Rench; Jon R Gentsch; Umesh D Parashar; Carol J Baker
Journal:  J Infect Dis       Date:  2012-08-07       Impact factor: 5.226

9.  Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.

Authors:  Xiaobo Wen; Dianjun Cao; Ronald W Jones; Jianping Li; Shousun Szu; Yasutaka Hoshino
Journal:  Vaccine       Date:  2012-08-09       Impact factor: 3.641

10.  Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.

Authors:  N Aliabadi; J E Tate; U D Parashar
Journal:  Clin Microbiol Infect       Date:  2016-04-26       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.